Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Renalytix Ai Plc ADR (RNLX)

Renalytix Ai Plc ADR (RNLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,183
  • Shares Outstanding, K 63,110
  • Annual Sales, $ 3,400 K
  • Annual Income, $ -45,610 K
  • 60-Month Beta 3.05
  • Price/Sales 14.08
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RNLX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.43
  • Most Recent Earnings $-0.09 on 02/14/24
  • Latest Earnings Date 06/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 260.94% ( +16.19%)
  • Historical Volatility 86.86%
  • IV Percentile 46%
  • IV Rank 30.26%
  • IV High 793.05% on 04/24/24
  • IV Low 30.03% on 08/11/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 74
  • Volume Avg (30-Day) 79
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,591
  • Open Int (30-Day) 1,195

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +768,561.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5900 +18.66%
on 04/26/24
0.9400 -25.52%
on 04/12/24
-0.1088 (-13.45%)
since 04/03/24
3-Month
0.2505 +179.48%
on 02/06/24
2.4000 -70.83%
on 02/12/24
+0.3877 (+124.10%)
since 02/02/24
52-Week
0.2449 +185.87%
on 01/19/24
4.0377 -82.66%
on 07/13/23
-1.5499 (-68.88%)
since 05/03/23

Most Recent Stories

More News
MarketBeat Podcast, 3 Small Caps With Big Upside

Today on The MarketBeat Podcast is Randy Baron, portfolio manager at Pinnacle Associates. Three stocks Randy discusses today have small market capitalizations.

AMRS : 0.0500 (-21.88%)
RNLX : 0.7001 (-7.76%)
WANSF : 0.5000 (unch)
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care Physicians

98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney...

RNLX : 0.7001 (-7.76%)
RENX.LN : 27.750 (-0.89%)
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022

LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro...

RNLX : 0.7001 (-7.76%)
RENX.LN : 27.750 (-0.89%)
Momentive (MNTV) Surges 10.1%: Is This an Indication of Further Gains?

Momentive (MNTV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

MNTV : 9.45 (unch)
RNLX : 0.7001 (-7.76%)
Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30

NEW YORK and SALT LAKE CITY, June 23, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will report its third...

RNLX : 0.7001 (-7.76%)
RENX.LN : 27.750 (-0.89%)
1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients

Late-breaking data presented at American Diabetes Association Scientific Sessions® demonstrates increased adherence to care guidelines for physicians using...

RNLX : 0.7001 (-7.76%)
RENX.LN : 27.750 (-0.89%)
KidneyIntelXâ„¢ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort

Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early...

RNLX : 0.7001 (-7.76%)
RENX.LN : 27.750 (-0.89%)
Renalytix Announces Two Data Presentations on KidneyIntelX™ at American Diabetes Association 82nd Scientific Sessions®

Real-world clinical utility in 1,112 patients tested with KidneyIntelX KidneyIntelX stratification for cardiovascular risk in 1,278 diabetic kidney...

RNLX : 0.7001 (-7.76%)
RENX.LN : 27.750 (-0.89%)
Renalytix plc successful completion of $30.0 million financing package

Director/PDMR Dealing...

RNLX : 0.7001 (-7.76%)
RENX.LN : 27.750 (-0.89%)
Renalytix plc Issue of shares

NEW YORK and SALT LAKE CITY, April 08, 2022 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) announces that under the Company's Employee...

RNLX : 0.7001 (-7.76%)
RENX.LN : 27.750 (-0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Renalytix AI plc is an artificial intelligence-enabled in vitro diagnostics company. It focuses on optimizing clinical management of kidney disease. Renalytix AI plc is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 0.9554
2nd Resistance Point 0.8767
1st Resistance Point 0.7884
Last Price 0.7001
1st Support Level 0.6214
2nd Support Level 0.5427
3rd Support Level 0.4544

See More

52-Week High 4.0377
Fibonacci 61.8% 2.5889
Fibonacci 50% 2.1413
Fibonacci 38.2% 1.6937
Last Price 0.7001
52-Week Low 0.2449

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar